Tag Archives: innovation

Innovation Is… with Stephan Tanda, Managing Board Member, Royal DSM

ST-115x76

The term “innovation” is thrown around more often than Peyton Manning’s name during Fantasy Football season. But if any industry can truly capture the essence of innovation, it is the biotech industry. Innovation is inherent in what we do – from curing or treating illnesses that were once considered a death sentence to feeding a growing population to helping to reduce our dependence on foreign oil through the production of biofuels. But what is innovation, Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

Innovative Companies and Investment Trends in Clean Tech at World Congress

Plenary Speakers on stage 1

A recent Reuters article says the U.S. biotech sector is picking up steam in 2013 as deals are happening and attractive returns are generated. According to Reuters, “biotech IPOs have turned in a strong performance, delivering an average return of about 20 percent this year, compared with an average of 16 percent across all sectors.” This article focuses on IPOs for health biotech companies, but there is also a lot going on right now in Read More >

Biofuels & Climate Change  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Roundtable Discussion Highlights Innovation, Commercial Reality for Renewable Chemical Products

biofuels

Last week BIO brought together representatives from five renewable chemical companies that will be speaking at BIO’s World Congress on Industrial Biotechnology next month in Montreal for a roundtable discussion highlighting developments in the renewable chemical space. Bioformix, Itaconix, Newlight Technologies, Solegear and CO2 Solutions are all in the early stages of commercializing innovative renewable chemical products making it a very exciting time for the industry. “Renewable chemicals can already compete on cost with petroleum Read More >

Biofuels & Climate Change  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

Opening Up Innovation

Cancer

Open Innovation has become a major theme in the life sciences over the last couple of years. Most of the attention has focused on initiatives where big pharma offers access to non-core assets to outside researchers in the hope that they will develop them successfully or form collaborations. In Sweden, AstraZeneca have followed this path, but interest in the concept has spread further down the discovery chain, generating creative initiatives from universities, tech transfer organizations, Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

BayBio Op-ed featured in Xconomy

GM

Gail Maderis, President & CEO of BayBio, recently discussed the strength of Northern California’s biotechnology industry and the BIO Investor Forum in Xconomy: With more than 850 biotechnology companies, the Bay Area is the oldest, largest and most productive life sciences cluster in the world, employing more than 125,000 people in the region. For more than 30 years, this region has led the world in researching and delivering new cures and treatments for debilitating diseases Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , , , , , ,